<DOC>
	<DOCNO>NCT01309061</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety autologous transplantation adipose tissue derive mesenchymal stem cell ( MSCs ) patient progressive hemifacial atrophy .</brief_summary>
	<brief_title>The Effect Human Adipose Tissue-derived MSCs Romberg 's Disease</brief_title>
	<detailed_description>Adipose derive mesenchymal stem cell ( AdMSCs ) represent attractive ethical cell source stem cell therapy . With recent demonstration MSC homing property , intramuscular aplications MSCs cell-damaged disease increase . In human clinical trial , five patient suffer progressive hemifacial atrophy ( Romberg 's disease ) intramuscular administer autologous hAdMSCs ( 1Ã—10e7 cells/500ul ) autologous microlipoinjection one time .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Facial Hemiatrophy</mesh_term>
	<criteria>Subjects understand sign consent form study . Age :1875 , males female . Patients symptom hemifacial atrophy progress disease . Patients currently progressive hemifacial atrophy . Women pregnant breast feed plan become pregnant study . Subjects n't understand purpose method study . Patients psychical disorder drug alcohol addiction . Participation another clinical trial treatment different investigational product within 30 day prior inclusion study . Serious preexist medical condition like Cardiovascular Diseases , Renal Diseases , Liver Diseases , Endocrine Diseases , Cancer Diabetes Mellitus . Other pathologic condition circumstance difficult participation study accord medical criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>